These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35753174)

  • 1. Comparative evaluation of four commercial analyzers for the serological screening of hepatitis A, B, C and HIV.
    Kutvonen H; Jarva H; Lappalainen M; Kurkela S
    J Clin Virol; 2022 Aug; 153():105219. PubMed ID: 35753174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance evaluation of immunoassay for infectious diseases on the Alinity i system.
    Nam M; Song DY; Song SH; Roh EY; Shin S; Park KU; Song EY
    J Clin Lab Anal; 2021 Mar; 35(3):e23671. PubMed ID: 33283340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
    Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
    J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the predictive value of the HIV Ag/Ab screening assay within the performance characteristics of the DiaSorin LIAISON XL for the detection of blood-borne viruses.
    Thai KTD; Götz H; Slingerland BCGC; Klaasse J; Schutten M; GeurtsvanKessel CH
    J Clin Virol; 2018 May; 102():95-100. PubMed ID: 29547874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: correlation with the ARCHITECT quantitative assays.
    Burdino E; Ruggiero T; Proietti A; Milia MG; Olivero A; Caviglia GP; Marietti M; Rizzetto M; Smedile A; Ghisetti V
    J Clin Virol; 2014 Aug; 60(4):341-6. PubMed ID: 24930708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories.
    Harritshøj LH; Gybel-Brask M; Afzal S; Kamstrup PR; Jørgensen CS; Thomsen MK; Hilsted L; Friis-Hansen L; Szecsi PB; Pedersen L; Nielsen L; Hansen CB; Garred P; Korsholm TL; Mikkelsen S; Nielsen KO; Møller BK; Hansen AT; Iversen KK; Nielsen PB; Hasselbalch RB; Fogh K; Norsk JB; Kristensen JH; Schønning K; Kirkby NS; Nielsen ACY; Landsy LH; Loftager M; Holm DK; Nilsson AC; Sækmose SG; Grum-Schwensen B; Aagaard B; Jensen TG; Nielsen DM; Ullum H; Dessau RB
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33574119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dried blood spot testing using the Abbott Alinity i.
    Shepherd SJ; McLellan H; Bell J; Gunson RN
    J Clin Virol; 2020 Nov; 132():104638. PubMed ID: 33049642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two new HTLV-I/II screening methods, Abbott Alinity i rHTLV-I/II and Diasorin LIAISON® XL murex recHTLV-I/II, to Abbott architect rHTLVI/II assay.
    Guiraud V; Crémoux F; Leroy I; Cohier J; Hernandez P; Mansaly S; Gautheret-Dejean A
    J Clin Virol; 2023 Jul; 164():105446. PubMed ID: 37148674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay Sensitivity Difference Can Induce Anti-Hepatitis A Virus IgM Non-Reactive But Total (IgM and IgG) Reactive Results in Early Acute Hepatitis A.
    Kim SK; Yoo K; Huh J
    J Korean Med Sci; 2022 Sep; 37(37):e287. PubMed ID: 36163480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-speed centrifugation rather than Lipoclear reagent can be used for removing the interference of lipemia on serological tests of infectious diseases: AIDS, hepatitis B, hepatitis C, and syphilis by chemiluminescent microparticle immunoassay.
    Liu W; Li L; Yin M; Cao C; Song Y; Long X
    J Med Virol; 2024 Feb; 96(2):e29385. PubMed ID: 38318918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification.
    Ross RS; Stambouli O; Grüner N; Marcus U; Cai W; Zhang W; Zimmermann R; Roggendorf M
    Virol J; 2013 Mar; 10():72. PubMed ID: 23497102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the test results on hepatitis B pilot surveillance labortory in 9 provinces of China].
    Wang FZ; Cui FQ; Gong XH
    Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):203-6, 274. PubMed ID: 20726257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of specific anti-HBO immunoglobulin of IgM or IgG type. Relation to other virus HB markers].
    Maniez-Montreuil M; Dupressoir-Burlet MV; Goudemand M
    Rev Fr Transfus Immunohematol; 1982 Jun; 25(3):245-63. PubMed ID: 7111979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.
    Pancher M; Désiré N; Ngo Y; Akhavan S; Pallier C; Poynard T; Thibault V
    J Clin Virol; 2015 Jan; 62():32-7. PubMed ID: 25542467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
    Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B.
    Rodella A; Galli C; Terlenghi L; Perandin F; Bonfanti C; Manca N
    J Clin Virol; 2006 Nov; 37(3):206-12. PubMed ID: 16893678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
    Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
    Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers].
    Wu X; Zhou C; Huang WJ; Qi ZB; Liang ZL; Li HM; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):915-8. PubMed ID: 19173858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.